Antios Therapeutics’ ATI-2173 Demonstrates Suppression of Hepatitis B Virus in Phase 2a Study; ATI-1428 and ATI-1645 Exhibit Potent Antiviral Activity in a Nonclinical Study – QNT Press Release4 years ago
ROSEN, A LEADING LAW FIRM, Encourages Apyx Medical Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – APYX – QNT Press Release4 years ago
Ionis announces presentation of positive Phase 2b data for chronic hepatitis B treatment at the EASL International Liver Congress™ – QNT Press Release4 years ago
Linens & Hutch Handmade Oversized Chunky Knit Throw Blankets only $49.99 shipped (Reg. $200!)4 years ago
